Startup Profile: Lactiga (020)

Episode 20 • September 05, 2021 • 00:48:50
Startup Profile: Lactiga (020)
Innovation4Alpha
Startup Profile: Lactiga (020)

Sep 05 2021 | 00:48:50

/

Show Notes

Lactiga is a venture-backed, NIH-funded biotherapeutics company developing patented biologics to treat and prevent mucosal infections with a focus on improving the quality of life in patients with Primary Immunodeficiency Diseases. They are unlocking the full therapeutic value of human milk antibodies to create the next-generation of anti-infectives that can battle even the world’s most dangerous pathogens including Covid. Lactiga has earned multiple awards, media attention (Globe & Mail, CTV, Toronto Star) and is participating in the On Deck Health (ODH2) cohort.

AngelMD Profile: https://www.angelmd.co/en/startups/lactiga

Other Episodes

Episode 229

August 21, 2022 • 00:13:52
Episode Cover

Mark Cherney: Founder, US Urology Partners - The State of Private Equity (229)

Mark Cherney is the Founder and Executive Chairman of both US Urology Partners and Prologics. This past year Mark transitioned from the CEO role...

Listen

Episode 30

August 24, 2022 • 00:28:03
Episode Cover

Pacific Echelon Security Services: Innovation & Hyper Growth in Physical Security (230)

Alex Stone is the Founder/CEO of Pacific Echelon Security Services, one of the fastest growing security companies in the United States.  The company is...

Listen

Episode 18

August 30, 2021 • 00:42:32
Episode Cover

Julie Anderson of Cambia Grove (018)

Julie Anderson is the Director of Strategic Initiatives at Cambia Grove and a healthcare veteran.Cambia Grove is a health care innovation hub focused on...

Listen